Carlos García Palenciano-rekin lankidetzan egindako argitalpenak (5)

2023

  1. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy

    Cell Reports Medicine, Vol. 4, Núm. 12

  2. Purinergic P2X7 receptor expression increases in leukocytes from intra-abdominal septic patients

    Frontiers in Immunology, Vol. 14

  3. The prognostic impact of SIGLEC5-induced impairment of CD8+ T cell activation in sepsis

    eBioMedicine, Vol. 97

2020

  1. Cd14 release induced by p2x7 receptor restricts inflammation and increases survival during sepsis

    eLife, Vol. 9, pp. 1-21

2019

  1. P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis

    Nature Communications, Vol. 10, Núm. 1